Disruption of NIPBL interactions led to decreased BCL11A expression.
Derepression of globin was observed as a consequence of ASO treatment.
Abstract
targeting these eRNAs with ASOs can disrupt NIPBL interactions, and promoter recruitment to the ACH, resulting in BCL11A gene silencing and derepression of -globin to a remarkable degree.
Ask AI
Helpful
Bookmark
Share
View Full Paper
Cite This Study
Dimitrios Mougiakakos (2026) studied this question.